Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ANI Pharmaceuticals, Inc. - Common Stock (NQ:ANIP)

95.05 -0.95 (-0.99%)
Streaming Delayed Price Updated: 11:47 AM EDT, Sep 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 115,570
Open 95.65
Bid (Size) 94.96 (1)
Ask (Size) 95.25 (2)
Prev. Close 96.00
Today's Range 93.98 - 96.56
52wk Range 52.50 - 96.37
Shares Outstanding 24,422,240
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
A Look Back at Generic Pharmaceuticals Stocks’ Q2 Earnings: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Pack
As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the generic pharmaceuticals industry, including Amphastar Pharmaceuticals (NASDAQ:AMPH) and its peers. 
Via StockStory
Topics Artificial Intelligence Intellectual Property
Generic Pharmaceuticals Stocks Q2 Earnings: ANI Pharmaceuticals (NASDAQ:ANIP) Best of the Bunch
Wrapping up Q2 earnings, we look at the numbers and key takeaways for the generic pharmaceuticals stocks, including ANI Pharmaceuticals (NASDAQ:ANIP) and its peers. 
Via StockStory
Topics Artificial Intelligence Intellectual Property

Performance

YTD
+71.4%
+71.4%
1 Month
+44.3%
+44.3%
3 Month
+58.7%
+58.7%
6 Month
+55.7%
+55.7%
1 Year
+51.0%
+51.0%

More News

Read More
ANI Pharmaceuticals Inc (NASDAQ:ANIP) Shows Strong Momentum and Growth, Fitting Minervini's Trend-Following Criteria
Via Chartmill
1 Mooning Stock for Long-Term Investors and 2 That Underwhelm
Via StockStory
Topics Emissions
ANI Pharma Stock Shoots Through The Roof On Friday: CEO’s Confidence On Trump Tariff Impact, Guidance Lift, Upbeat Q2 Among Key Factors
Via Stocktwits
Topics Government
Earnings Preview For ANI Pharmaceuticals
Via Benzinga
Q2 Earnings Roundup: Viatris (NASDAQ:VTRS) And The Rest Of The Generic Pharmaceuticals Segment
Via StockStory
Topics Artificial Intelligence Intellectual Property
3 Healthcare Stocks We’re Skeptical Of
Via StockStory
Topics Stocks
Azenta, LifeStance Health Group, BioMarin Pharmaceutical, AMN Healthcare Services, and ANI Pharmaceuticals Stocks Trade Up, What You Need To Know
Via StockStory
Topics Earnings Economy
ANIP Q2 Deep Dive: Rare Disease Expansion Fuels Outperformance, Generics Maintain Solid Trajectory
Via StockStory
Why ANI Pharmaceuticals (ANIP) Stock Is Up Today
Via StockStory
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
ANI Pharmaceuticals Inc (NASDAQ:ANIP) Reports Record Q2 2025 Earnings, Beats Estimates and Raises Full-Year Guidance
Via Chartmill
Topics Earnings
ANI Pharmaceuticals’s (NASDAQ:ANIP) Q2: Strong Sales, Stock Soars
Via StockStory
Earnings Scheduled For August 8, 2025
Via Benzinga
ANI Pharmaceuticals (ANIP) Q2 Earnings: What To Expect
Via StockStory
Topics Government World Trade
Delaware Superior Court Jury Issues Unanimous Verdict that CG Oncology Owes No Future Royalties or Other Payments to ANI Pharmaceuticals
From CG Oncology Inc.
Via GlobeNewswire
Q1 Earnings Highs And Lows: Amneal (NASDAQ:AMRX) Vs The Rest Of The Generic Pharmaceuticals Stocks
Via StockStory
Topics Artificial Intelligence Intellectual Property
Q1 Earnings Highs And Lows: Viatris (NASDAQ:VTRS) Vs The Rest Of The Generic Pharmaceuticals Stocks
Via StockStory
Topics Artificial Intelligence Intellectual Property
3 Value Stocks Skating on Thin Ice
Via StockStory
3 Growth Stocks in Hot Water
Via StockStory
ANI Pharmaceuticals (NASDAQ:ANIP) Q1 Earnings: Leading The Generic Pharmaceuticals Pack
Via StockStory
Topics Artificial Intelligence Intellectual Property
3 of Wall Street’s Favorite Stocks with Questionable Fundamentals
Via StockStory
3 Healthcare Stocks with Mounting Challenges
Via StockStory
Topics Stocks
3 Cash-Producing Stocks in the Doghouse
Via StockStory

Frequently Asked Questions

Is ANI Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, ANI Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does ANI Pharmaceuticals, Inc. - Common Stock trade on?
ANI Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for ANI Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for ANI Pharmaceuticals, Inc. - Common Stock is ANIP on the Nasdaq Stock Market
What is the current price of ANI Pharmaceuticals, Inc. - Common Stock?
The current price of ANI Pharmaceuticals, Inc. - Common Stock is 95.05
When was ANI Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of ANI Pharmaceuticals, Inc. - Common Stock was at 09/05/25 11:47 AM ET
What is the market capitalization of ANI Pharmaceuticals, Inc. - Common Stock?
The market capitalization of ANI Pharmaceuticals, Inc. - Common Stock is 2.32B
How many shares of ANI Pharmaceuticals, Inc. - Common Stock are outstanding?
ANI Pharmaceuticals, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.